Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 30-Jun 2022. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 5072402011 | Product containing precisely amoxicillin 400 milligram and clavulanic acid (as clavulanate potassium) 57 milligram/1 each conventional release oral tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 5072403018 | Amoxicillin 400 mg and clavulanic acid (as clavulanate potassium) 57 mg oral tablet | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely amoxicillin 400 milligram and clavulanic acid (as clavulanate potassium) 57 milligram/1 each conventional release oral tablet (clinical drug) | est un(e) (attribut) | Amoxicillin and clavulanic acid only product in oral dose form | true | Inferred relationship | Some | ||
| Product containing precisely amoxicillin 400 milligram and clavulanic acid (as clavulanate potassium) 57 milligram/1 each conventional release oral tablet (clinical drug) | a une forme pharmaceutique (attribut) | Oral tablet | true | Inferred relationship | Some | ||
| Product containing precisely amoxicillin 400 milligram and clavulanic acid (as clavulanate potassium) 57 milligram/1 each conventional release oral tablet (clinical drug) | Has unit of presentation | Tablet (unit of presentation) | true | Inferred relationship | Some | ||
| Product containing precisely amoxicillin 400 milligram and clavulanic acid (as clavulanate potassium) 57 milligram/1 each conventional release oral tablet (clinical drug) | Plays role | Antibacterial therapeutic role (role) | true | Inferred relationship | Some | ||
| Product containing precisely amoxicillin 400 milligram and clavulanic acid (as clavulanate potassium) 57 milligram/1 each conventional release oral tablet (clinical drug) | Has precise active ingredient | Amoxicillin (substance) | true | Inferred relationship | Some | 1 | |
| Product containing precisely amoxicillin 400 milligram and clavulanic acid (as clavulanate potassium) 57 milligram/1 each conventional release oral tablet (clinical drug) | Has basis of strength substance (attribute) | Amoxicillin (substance) | true | Inferred relationship | Some | 1 | |
| Product containing precisely amoxicillin 400 milligram and clavulanic acid (as clavulanate potassium) 57 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator unit | milligram (qualifier value) | true | Inferred relationship | Some | 1 | |
| Product containing precisely amoxicillin 400 milligram and clavulanic acid (as clavulanate potassium) 57 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | true | Inferred relationship | Some | 1 | |
| Product containing precisely amoxicillin 400 milligram and clavulanic acid (as clavulanate potassium) 57 milligram/1 each conventional release oral tablet (clinical drug) | Has precise active ingredient | Clavulanate potassium (substance) | true | Inferred relationship | Some | 2 | |
| Product containing precisely amoxicillin 400 milligram and clavulanic acid (as clavulanate potassium) 57 milligram/1 each conventional release oral tablet (clinical drug) | Has basis of strength substance (attribute) | Clavulanic acid (substance) | true | Inferred relationship | Some | 2 | |
| Product containing precisely amoxicillin 400 milligram and clavulanic acid (as clavulanate potassium) 57 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator unit | milligram (qualifier value) | true | Inferred relationship | Some | 2 | |
| Product containing precisely amoxicillin 400 milligram and clavulanic acid (as clavulanate potassium) 57 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | true | Inferred relationship | Some | 2 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR